Lindbrook Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.03K | Buy |
576
+214
| +59% | +$1.87K | ﹤0.01% | 1948 |
|
|
2024
Q4 | $5.2K | Sell |
362
-515
| -59% | -$7.4K | ﹤0.01% | 1970 |
|
|
2024
Q3 | $19.8K | Buy |
877
+549
| +167% | +$12.4K | ﹤0.01% | 1305 |
|
|
2024
Q2 | $6.38K | Buy |
328
+259
| +375% | +$5.04K | ﹤0.01% | 1874 |
|
|
2024
Q1 | $2.59K | Buy |
69
+1
| +1% | +$38 | ﹤0.01% | 2151 |
|
|
2023
Q4 | $3.81K | Sell |
68
-134
| -66% | -$7.5K | ﹤0.01% | 2025 |
|
|
2023
Q3 | $8.33K | Sell |
202
-12
| -6% | -$495 | ﹤0.01% | 1505 |
|
|
2023
Q2 | $12K | Buy |
214
+12
| +6% | +$670 | ﹤0.01% | 1357 |
|
|
2023
Q1 | $11.3K | Buy |
202
+17
| +9% | +$948 | ﹤0.01% | 1373 |
|
|
2022
Q4 | $6.74K | Buy |
185
+177
| +2,213% | +$6.45K | ﹤0.01% | 1647 |
|
|
2022
Q3 | $0 | Sell |
8
-3
| -27% | – | ﹤0.01% | 2931 |
|
|
2022
Q2 | $0 | Sell |
11
-24
| -69% | – | ﹤0.01% | 2802 |
|
|
2022
Q1 | $3K | Sell |
35
-40
| -53% | -$3.43K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $11K | Buy |
75
+55
| +275% | +$8.07K | ﹤0.01% | 1243 |
|
|
2021
Q3 | $3K | Buy |
+20
| New | +$3K | ﹤0.01% | 1450 |
|